BioAge Labs (BIOA) Non-Current Assets (2023 - 2026)
BioAge Labs' (BIOA) quarterly Non-Current Assets came in at $5.8 million in Q1 2026, down 69.55% year-on-year from $19.0 million in Q1 2025, and down 28.43% quarter-over-quarter from $8.1 million in Q4 2025.
BioAge Labs (BIOA) Non-Current Assets (2023 - 2026) Analysis & Trends
BioAge Labs has disclosed Non-Current Assets across 4 years of filings, most recently posting $5.8 million for Q1 2026.
- Non-Current Assets for Q1 2026 came in at $5.8 million, down 69.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $48.6 million (up 124.07% YoY), and the FY2025 annual result was $8.1 million, up 615.83% from the prior year.
- Non-Current Assets came in at $5.8 million for Q1 2026 at BioAge Labs, down from $8.1 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $20.5 million in Q2 2025 to a low of $618000.0 in Q4 2023.
- The 4-year median for Non-Current Assets is $6.9 million (2025), against an average of $8.8 million.
- Across the five-year window, Non-Current Assets soared 1460.39% in 2025 and sank 69.55% in 2026, its largest moves.
- BioAge Labs' Non-Current Assets stood at $618000.0 in 2023, then soared by 83.01% to $1.1 million in 2024, then soared by 615.83% to $8.1 million in 2025, then retreated by 28.43% to $5.8 million in 2026.
- The last three Non-Current Assets figures came in at $5.8 million (Q1 2026), $8.1 million (Q4 2025), and $14.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.22 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.40 Bn |
| 10 | BioAge Labs | 671.19 Mn | 288.00 Mn | -10.37 Mn | 5.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.79 Mn |
| Dec 31, 2025 | 8.10 Mn |
| Sep 30, 2025 | 14.26 Mn |
| Jun 30, 2025 | 20.45 Mn |
| Mar 31, 2025 | 19.03 Mn |
| Dec 31, 2024 | 1.13 Mn |
| Sep 30, 2024 | 914,000.00 |
| Dec 31, 2023 | 618,000.00 |